June 25, 2017 9:30 PM ET


Company Overview of Velcura Therapeutics Inc.

Company Overview

Velcura Therapeutics, Inc., a bone disease biotechnology company, develops therapies to restore bone homeostasis and bone health. It develops therapies for the treatment of bone diseases, such as rheumatoid arthritis, multiple myeloma, bone metastases, and osteoporosis. Velcura Therapeutics, Inc. has a strategic partnership with Nippon Chemiphar Co., Ltd. Velcura Therapeutics, Inc. was formerly known as Osteomics Inc. The company was founded in 2001 and is based in Ann Arbor, Michigan.

4300 Varsity Drive

Suite D

Ann Arbor, MI 48108

United States

Founded in 2001





Key Executives for Velcura Therapeutics Inc.

Chief Financial Officer
Executive Vice President of Product Development
Executive Vice President of Corporate Development
Vice President of Corporate Development and Acting Director of Research
Vice President of Regulatory Affairs
Compensation as of Fiscal Year 2016.

Similar Private Companies By Industry

Company Name Region
20n Labs, Inc. United States
23andMe, Inc. United States
2C Tech Corporation, Inc. United States
3-V Biosciences, Inc. United States
3Bar Biologics Inc. United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
The Advertising Council, Inc. United States
Rush University United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Velcura Therapeutics Inc., please visit www.velcura.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.